3.5.0.2 html 229 352 1 true 85 0 false 4 false false R1.htm 000 - Document - Document And Entity Information Sheet http://cescatherapeutics.com/20160630/role/statement-document-and-entity-information Document And Entity Information Cover 1 false false R2.htm 001 - Statement - Consolidated Balance Sheets Sheet http://cescatherapeutics.com/20160630/role/statement-consolidated-balance-sheets Consolidated Balance Sheets Statements 2 false false R3.htm 002 - Statement - Consolidated Balance Sheets (Parentheticals) Sheet http://cescatherapeutics.com/20160630/role/statement-consolidated-balance-sheets-parentheticals Consolidated Balance Sheets (Parentheticals) Statements 3 false false R4.htm 003 - Statement - Consolidated Statements of Operations and Comprehensive Loss Sheet http://cescatherapeutics.com/20160630/role/statement-consolidated-statements-of-operations-and-comprehensive-loss Consolidated Statements of Operations and Comprehensive Loss Statements 4 false false R5.htm 004 - Statement - Consolidated Statements of Stockholders' Equity Sheet http://cescatherapeutics.com/20160630/role/statement-consolidated-statements-of-stockholders-equity Consolidated Statements of Stockholders' Equity Statements 5 false false R6.htm 005 - Statement - Consolidated Statements of Cash Flows Sheet http://cescatherapeutics.com/20160630/role/statement-consolidated-statements-of-cash-flows Consolidated Statements of Cash Flows Statements 6 false false R7.htm 006 - Disclosure - Note 1 - Description of Business and Basis of Presentation Sheet http://cescatherapeutics.com/20160630/role/statement-note-1-description-of-business-and-basis-of-presentation Note 1 - Description of Business and Basis of Presentation Notes 7 false false R8.htm 007 - Disclosure - Note 2 - Summary of Significant Accounting Policies Sheet http://cescatherapeutics.com/20160630/role/statement-note-2-summary-of-significant-accounting-policies Note 2 - Summary of Significant Accounting Policies Notes 8 false false R9.htm 008 - Disclosure - Note 3 - Intangible Assets Sheet http://cescatherapeutics.com/20160630/role/statement-note-3-intangible-assets Note 3 - Intangible Assets Notes 9 false false R10.htm 009 - Disclosure - Note 4 - Equipment Sheet http://cescatherapeutics.com/20160630/role/statement-note-4-equipment Note 4 - Equipment Notes 10 false false R11.htm 010 - Disclosure - Note 5 - Convertible Debentures Sheet http://cescatherapeutics.com/20160630/role/statement-note-5-convertible-debentures Note 5 - Convertible Debentures Notes 11 false false R12.htm 011 - Disclosure - Note 6 - Derivative Obligations Sheet http://cescatherapeutics.com/20160630/role/statement-note-6-derivative-obligations Note 6 - Derivative Obligations Notes 12 false false R13.htm 012 - Disclosure - Note 7 - Commitments and Contingencies Sheet http://cescatherapeutics.com/20160630/role/statement-note-7-commitments-and-contingencies Note 7 - Commitments and Contingencies Notes 13 false false R14.htm 013 - Disclosure - Note 8 - Stockholders' Equity Sheet http://cescatherapeutics.com/20160630/role/statement-note-8-stockholders-equity Note 8 - Stockholders' Equity Notes 14 false false R15.htm 014 - Disclosure - Note 9 - Concentrations Sheet http://cescatherapeutics.com/20160630/role/statement-note-9-concentrations Note 9 - Concentrations Notes 15 false false R16.htm 015 - Disclosure - Note 10 - Income Taxes Sheet http://cescatherapeutics.com/20160630/role/statement-note-10-income-taxes Note 10 - Income Taxes Notes 16 false false R17.htm 016 - Disclosure - Note 11 - Employee Retirement Plan Sheet http://cescatherapeutics.com/20160630/role/statement-note-11-employee-retirement-plan Note 11 - Employee Retirement Plan Notes 17 false false R18.htm 017 - Disclosure - Note 12 - Subsequent Events Sheet http://cescatherapeutics.com/20160630/role/statement-note-12-subsequent-events Note 12 - Subsequent Events Notes 18 false false R19.htm 018 - Disclosure - Significant Accounting Policies (Policies) Sheet http://cescatherapeutics.com/20160630/role/statement-significant-accounting-policies-policies Significant Accounting Policies (Policies) Policies http://cescatherapeutics.com/20160630/role/statement-note-2-summary-of-significant-accounting-policies 19 false false R20.htm 019 - Disclosure - Note 2 - Summary of Significant Accounting Policies (Tables) Sheet http://cescatherapeutics.com/20160630/role/statement-note-2-summary-of-significant-accounting-policies-tables Note 2 - Summary of Significant Accounting Policies (Tables) Tables http://cescatherapeutics.com/20160630/role/statement-note-2-summary-of-significant-accounting-policies 20 false false R21.htm 020 - Disclosure - Note 3 - Intangible Assets (Tables) Sheet http://cescatherapeutics.com/20160630/role/statement-note-3-intangible-assets-tables Note 3 - Intangible Assets (Tables) Tables http://cescatherapeutics.com/20160630/role/statement-note-3-intangible-assets 21 false false R22.htm 021 - Disclosure - Note 4 - Equipment (Tables) Sheet http://cescatherapeutics.com/20160630/role/statement-note-4-equipment-tables Note 4 - Equipment (Tables) Tables http://cescatherapeutics.com/20160630/role/statement-note-4-equipment 22 false false R23.htm 022 - Disclosure - Note 5 - Convertible Debentures (Tables) Sheet http://cescatherapeutics.com/20160630/role/statement-note-5-convertible-debentures-tables Note 5 - Convertible Debentures (Tables) Tables http://cescatherapeutics.com/20160630/role/statement-note-5-convertible-debentures 23 false false R24.htm 023 - Disclosure - Note 6 - Derivative Obligations (Tables) Sheet http://cescatherapeutics.com/20160630/role/statement-note-6-derivative-obligations-tables Note 6 - Derivative Obligations (Tables) Tables http://cescatherapeutics.com/20160630/role/statement-note-6-derivative-obligations 24 false false R25.htm 024 - Disclosure - Note 7 - Commitments and Contingencies (Tables) Sheet http://cescatherapeutics.com/20160630/role/statement-note-7-commitments-and-contingencies-tables Note 7 - Commitments and Contingencies (Tables) Tables http://cescatherapeutics.com/20160630/role/statement-note-7-commitments-and-contingencies 25 false false R26.htm 025 - Disclosure - Note 8 - Stockholders' Equity (Tables) Sheet http://cescatherapeutics.com/20160630/role/statement-note-8-stockholders-equity-tables Note 8 - Stockholders' Equity (Tables) Tables http://cescatherapeutics.com/20160630/role/statement-note-8-stockholders-equity 26 false false R27.htm 026 - Disclosure - Note 9 - Concentrations (Tables) Sheet http://cescatherapeutics.com/20160630/role/statement-note-9-concentrations-tables Note 9 - Concentrations (Tables) Tables http://cescatherapeutics.com/20160630/role/statement-note-9-concentrations 27 false false R28.htm 027 - Disclosure - Note 10 - Income Taxes (Tables) Sheet http://cescatherapeutics.com/20160630/role/statement-note-10-income-taxes-tables Note 10 - Income Taxes (Tables) Tables http://cescatherapeutics.com/20160630/role/statement-note-10-income-taxes 28 false false R29.htm 028 - Disclosure - Note 1 - Description of Business and Basis of Presentation (Details Textual) Sheet http://cescatherapeutics.com/20160630/role/statement-note-1-description-of-business-and-basis-of-presentation-details-textual Note 1 - Description of Business and Basis of Presentation (Details Textual) Details http://cescatherapeutics.com/20160630/role/statement-note-1-description-of-business-and-basis-of-presentation 29 false false R30.htm 029 - Disclosure - Note 2 - Summary of Significant Accounting Policies (Details Textual) Sheet http://cescatherapeutics.com/20160630/role/statement-note-2-summary-of-significant-accounting-policies-details-textual Note 2 - Summary of Significant Accounting Policies (Details Textual) Details http://cescatherapeutics.com/20160630/role/statement-note-2-summary-of-significant-accounting-policies-tables 30 false false R31.htm 030 - Disclosure - Note 2 - Calculation for Basic and Diluted Earnings Per Share (Details) Sheet http://cescatherapeutics.com/20160630/role/statement-note-2-calculation-for-basic-and-diluted-earnings-per-share-details Note 2 - Calculation for Basic and Diluted Earnings Per Share (Details) Details 31 false false R32.htm 031 - Disclosure - Note 3 - Intangible Assets (Details Textual) Sheet http://cescatherapeutics.com/20160630/role/statement-note-3-intangible-assets-details-textual Note 3 - Intangible Assets (Details Textual) Details http://cescatherapeutics.com/20160630/role/statement-note-3-intangible-assets-tables 32 false false R33.htm 032 - Disclosure - Note 3 - Intangible Assets Disclosure (Details) Sheet http://cescatherapeutics.com/20160630/role/statement-note-3-intangible-assets-disclosure-details Note 3 - Intangible Assets Disclosure (Details) Details 33 false false R34.htm 033 - Disclosure - Note 3 - Future Amortization Expense (Details) Sheet http://cescatherapeutics.com/20160630/role/statement-note-3-future-amortization-expense-details Note 3 - Future Amortization Expense (Details) Details 34 false false R35.htm 034 - Disclosure - Note 4 - Equipment (Details Textual) Sheet http://cescatherapeutics.com/20160630/role/statement-note-4-equipment-details-textual Note 4 - Equipment (Details Textual) Details http://cescatherapeutics.com/20160630/role/statement-note-4-equipment-tables 35 false false R36.htm 035 - Disclosure - Note 4 - Property, Plant, and Equipment (Details) Sheet http://cescatherapeutics.com/20160630/role/statement-note-4-property-plant-and-equipment-details Note 4 - Property, Plant, and Equipment (Details) Details 36 false false R37.htm 036 - Disclosure - Note 5 - Convertible Debentures (Details Textual) Sheet http://cescatherapeutics.com/20160630/role/statement-note-5-convertible-debentures-details-textual Note 5 - Convertible Debentures (Details Textual) Details http://cescatherapeutics.com/20160630/role/statement-note-5-convertible-debentures-tables 37 false false R38.htm 037 - Disclosure - Note 5 - Convertible Debentures Components (Details) Sheet http://cescatherapeutics.com/20160630/role/statement-note-5-convertible-debentures-components-details Note 5 - Convertible Debentures Components (Details) Details 38 false false R39.htm 038 - Disclosure - Note 5 - Schedule of Extinguishment of Debt (Details) Sheet http://cescatherapeutics.com/20160630/role/statement-note-5-schedule-of-extinguishment-of-debt-details Note 5 - Schedule of Extinguishment of Debt (Details) Details 39 false false R40.htm 039 - Disclosure - Note 6 - Derivative Obligations (Details Textual) Sheet http://cescatherapeutics.com/20160630/role/statement-note-6-derivative-obligations-details-textual Note 6 - Derivative Obligations (Details Textual) Details http://cescatherapeutics.com/20160630/role/statement-note-6-derivative-obligations-tables 40 false false R41.htm 040 - Disclosure - Note 6 - Derivative Obligations, Fair Value Assumptions (Details) Sheet http://cescatherapeutics.com/20160630/role/statement-note-6-derivative-obligations-fair-value-assumptions-details Note 6 - Derivative Obligations, Fair Value Assumptions (Details) Details 41 false false R42.htm 041 - Disclosure - Note 6 - Derivative Obligation Fair Value Hierarchy (Details) Sheet http://cescatherapeutics.com/20160630/role/statement-note-6-derivative-obligation-fair-value-hierarchy-details Note 6 - Derivative Obligation Fair Value Hierarchy (Details) Details 42 false false R43.htm 042 - Disclosure - Note 6 - Change in Fair Value of Derivative Liabilities (Details) Sheet http://cescatherapeutics.com/20160630/role/statement-note-6-change-in-fair-value-of-derivative-liabilities-details Note 6 - Change in Fair Value of Derivative Liabilities (Details) Details 43 false false R44.htm 043 - Disclosure - Note 7 - Commitments and Contingencies (Details Textual) Sheet http://cescatherapeutics.com/20160630/role/statement-note-7-commitments-and-contingencies-details-textual Note 7 - Commitments and Contingencies (Details Textual) Details http://cescatherapeutics.com/20160630/role/statement-note-7-commitments-and-contingencies-tables 44 false false R45.htm 044 - Disclosure - Note 7 - Future Minimum Lease Payments for Non-Cancelable Operating Lease (Details) Sheet http://cescatherapeutics.com/20160630/role/statement-note-7-future-minimum-lease-payments-for-noncancelable-operating-lease-details Note 7 - Future Minimum Lease Payments for Non-Cancelable Operating Lease (Details) Details 45 false false R46.htm 045 - Disclosure - Note 7 - Changes in Product Liability Included in Accrued Liabilities (Details) Sheet http://cescatherapeutics.com/20160630/role/statement-note-7-changes-in-product-liability-included-in-accrued-liabilities-details Note 7 - Changes in Product Liability Included in Accrued Liabilities (Details) Details 46 false false R47.htm 046 - Disclosure - Note 8 - Stockholders' Equity (Details Textual) Sheet http://cescatherapeutics.com/20160630/role/statement-note-8-stockholders-equity-details-textual Note 8 - Stockholders' Equity (Details Textual) Details http://cescatherapeutics.com/20160630/role/statement-note-8-stockholders-equity-tables 47 false false R48.htm 047 - Disclosure - Note 8 - Warrant Activity (Details) Sheet http://cescatherapeutics.com/20160630/role/statement-note-8-warrant-activity-details Note 8 - Warrant Activity (Details) Details 48 false false R49.htm 048 - Disclosure - Note 8 - Option Activity For Stock Option Plans (Details) Sheet http://cescatherapeutics.com/20160630/role/statement-note-8-option-activity-for-stock-option-plans-details Note 8 - Option Activity For Stock Option Plans (Details) Details 49 false false R50.htm 049 - Disclosure - Note 8 - Non-vested Stock Options Activity (Details) Sheet http://cescatherapeutics.com/20160630/role/statement-note-8-nonvested-stock-options-activity-details Note 8 - Non-vested Stock Options Activity (Details) Details 50 false false R51.htm 050 - Disclosure - Note 8 - Fair Value of Stock Options Granted (Details) Sheet http://cescatherapeutics.com/20160630/role/statement-note-8-fair-value-of-stock-options-granted-details Note 8 - Fair Value of Stock Options Granted (Details) Details 51 false false R52.htm 051 - Disclosure - Note 8 - Restricted Stock Activity Granted to Employees (Details) Sheet http://cescatherapeutics.com/20160630/role/statement-note-8-restricted-stock-activity-granted-to-employees-details Note 8 - Restricted Stock Activity Granted to Employees (Details) Details 52 false false R53.htm 052 - Disclosure - Note 9 - Concentrations (Details Textual) Sheet http://cescatherapeutics.com/20160630/role/statement-note-9-concentrations-details-textual Note 9 - Concentrations (Details Textual) Details http://cescatherapeutics.com/20160630/role/statement-note-9-concentrations-tables 53 false false R54.htm 053 - Disclosure - Note 9 - Revenues by Product Platform (Details) Sheet http://cescatherapeutics.com/20160630/role/statement-note-9-revenues-by-product-platform-details Note 9 - Revenues by Product Platform (Details) Details 54 false false R55.htm 054 - Disclosure - Note 9 - Sales to Customers (Details) Sheet http://cescatherapeutics.com/20160630/role/statement-note-9-sales-to-customers-details Note 9 - Sales to Customers (Details) Details 55 false false R56.htm 055 - Disclosure - Note 9 - Summary of Net Equipment by Geographic Area (Details) Sheet http://cescatherapeutics.com/20160630/role/statement-note-9-summary-of-net-equipment-by-geographic-area-details Note 9 - Summary of Net Equipment by Geographic Area (Details) Details 56 false false R57.htm 056 - Disclosure - Note 10 - Income Taxes (Details Textual) Sheet http://cescatherapeutics.com/20160630/role/statement-note-10-income-taxes-details-textual Note 10 - Income Taxes (Details Textual) Details http://cescatherapeutics.com/20160630/role/statement-note-10-income-taxes-tables 57 false false R58.htm 057 - Disclosure - Note 10 - Reconciliation of Federal Income Tax Attributable to Operations to Income Tax Expense (Benefit) (Details) Sheet http://cescatherapeutics.com/20160630/role/statement-note-10-reconciliation-of-federal-income-tax-attributable-to-operations-to-income-tax-expense-benefit-details Note 10 - Reconciliation of Federal Income Tax Attributable to Operations to Income Tax Expense (Benefit) (Details) Details 58 false false R59.htm 058 - Disclosure - Note 10 - Components of Company's Deferred Tax Assets and Liabilities for Federal and State Income Taxes (Details) Sheet http://cescatherapeutics.com/20160630/role/statement-note-10-components-of-companys-deferred-tax-assets-and-liabilities-for-federal-and-state-income-taxes-details Note 10 - Components of Company's Deferred Tax Assets and Liabilities for Federal and State Income Taxes (Details) Details 59 false false R60.htm 059 - Disclosure - Note 11 - Employee Retirement Plan (Details Textual) Sheet http://cescatherapeutics.com/20160630/role/statement-note-11-employee-retirement-plan-details-textual Note 11 - Employee Retirement Plan (Details Textual) Details http://cescatherapeutics.com/20160630/role/statement-note-11-employee-retirement-plan 60 false false R61.htm 060 - Disclosure - Note 12 - Subsequent Events (Details Textual) Sheet http://cescatherapeutics.com/20160630/role/statement-note-12-subsequent-events-details-textual Note 12 - Subsequent Events (Details Textual) Details http://cescatherapeutics.com/20160630/role/statement-note-12-subsequent-events 61 false false All Reports Book All Reports kool-20160630.xml kool-20160630.xsd kool-20160630_cal.xml kool-20160630_def.xml kool-20160630_lab.xml kool-20160630_pre.xml true true